Borregaard (OB:BRG): Assessing Valuation After NOK 15 Million Grant Fuels Sustainable Biomer Initiative

Reviewed by Kshitija Bhandaru
Borregaard (OB:BRG) just received NOK 15 million from the Norwegian Research Council to advance its Biomer project, an effort focused on developing greener, bio-based alternatives to conventional fossil-derived polymers commonly found in agriculture and industry.
See our latest analysis for Borregaard.
While Borregaard’s NOK 15 million grant puts a spotlight on its sustainability push, the momentum in the stock has been relatively steady. Its latest share price sits at NOK 191.0, and over the last year, total shareholder return has essentially held flat. However, looking at the three- and five-year horizons, long-term investors have seen healthy gains, pointing to resilience beyond short-term fluctuations.
If this move towards greener chemicals has you thinking bigger, now's an ideal time to broaden your search and discover fast growing stocks with high insider ownership
The real question for investors is whether Borregaard’s green shift means the stock is actually undervalued today, or if the share price has already factored in its promising outlook for sustainable growth.
Most Popular Narrative: 12% Undervalued
Borregaard’s most widely followed narrative sees a clear upside. With a fair value set above the last close, the narrative’s target reflects optimism for the company’s outlook and execution. The price target sits notably above today’s market price, drawing from a blend of industry, operational, and financial forecasts.
Strong demand for green products and high-value specialties is expected to boost sales and margins, driving revenue growth for Borregaard. Operational improvements and currency hedging could stabilize revenue and enhance financial resilience despite trade and currency challenges.
Why does the market see so much potential? Only a handful of key assumptions about revenue growth, margin expansion, and future earnings drive this optimistic fair value. These are numbers that might surprise you. Want to know what justifies the bullish consensus and how Borregaard’s story stacks up to sector averages? Dive in to uncover the pivotal projections that determine this valuation.
Result: Fair Value of $217.5 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, higher wood and logistical costs, as well as new tariffs on exports to the U.S., could quickly weigh on Borregaard’s margins and growth outlook.
Find out about the key risks to this Borregaard narrative.
Build Your Own Borregaard Narrative
If you see things differently or want to dig into the numbers yourself, you can easily shape your own view in just a few minutes. Do it your way
A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Borregaard.
Looking for More Investment Ideas?
Great investors never settle for one opportunity. Broaden your investment horizons with handpicked stocks designed to match your curiosity and ambition for growth.
- Uncover the next wave of market disruptors by exploring these 24 AI penny stocks, which are making headlines for rapid innovation and artificial intelligence breakthroughs.
- Maximize your returns with steady income by tapping into these 19 dividend stocks with yields > 3%, which consistently deliver attractive yields and reward long-term holders.
- Get ahead of market trends by targeting growth potential within these 3563 penny stocks with strong financials, which show resilience and strong fundamentals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Borregaard might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About OB:BRG
Borregaard
Engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally.
Flawless balance sheet and fair value.
Similar Companies
Market Insights
Community Narratives


